🇺🇸 KIMBERLY-CLARK BUYING TYLENOL MAKER KENVUE FOR $48.7 BILLION Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating one of America's biggest consumer health companies. The merger brings together Neutrogena, Huggies, Kleenex, and Tylenol under one roof with expected annual revenues of $32 billion. Kenvue has been struggling with leadership shake-ups, mounting litigation risks, and fresh scrutiny after Trump admin linked Tylenol to autism. The company was spun off from Johnson & Johnson in 2023 and has been under strategic review since. Source: Reuters